Arecor Therapeutics PLC (AREC)

London
405.00
0.00(0.00%)
  • Volume:
    0
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    405.00 - 405.00

AREC Overview

Prev. Close
405
Day's Range
405-405
Revenue
-
Open
405
52 wk Range
222-472
EPS
-
Volume
0
Market Cap
112.73M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
17,181
P/E Ratio
-
Beta
-
1-Year Change
-
Shares Outstanding
27,835,024
Next Earnings Date
-
What is your sentiment on Arecor Therapeutics PLC?
or
Vote to see community's results!

Arecor Therapeutics PLC News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellSellSellBuyStrong Buy
Technical IndicatorsStrong SellSellStrong SellStrong BuyBuy
SummaryStrong SellSellStrong SellStrong BuyStrong Buy

Arecor Therapeutics PLC Company Profile

Arecor Therapeutics PLC Company Profile

Employees
0

Arecor Therapeutics PLC, a biopharmaceutical company, focuses on developing products in diabetes and other indications. The company through its proprietary formulation technology platform, Arestat, developing a portfolio of proprietary products in diabetes and other indications, as well as working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of therapeutic products. It is developing AT247, an ultra-rapid acting insulin for patients with Type I and Type II diabetics; and AT278, an ultra-concentrated rapid acting insulin formulation that has been designed to accelerate the absorption of insulin post injection. The company was founded in 2007 and is headquartered in Little Chesterford, the United Kingdom.

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.